Zealand Pharma A/S
ZLDPF
$61.00
$3.506.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2,535.43% | -13.73% | -5.95% | 7.07% | -26.88% |
| Total Depreciation and Amortization | 12.40% | 65.86% | -44.45% | -6.51% | 1.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14,015.86% | 117.86% | -123.67% | -142.32% | 1,451.46% |
| Change in Net Operating Assets | 43.75% | -231.94% | 902.08% | -283.51% | 296.06% |
| Cash from Operations | 1,934.45% | -173.89% | 40.73% | -30.38% | -2.49% |
| Capital Expenditure | -7.32% | -441.58% | -353.10% | 94.95% | -42.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | -414.57% | 249.18% | 102.43% | -24,390.43% | 98.17% |
| Cash from Investing | -406.08% | 263.15% | 102.41% | -20,290.95% | 97.81% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -2.12% | 5.45% | -9.71% | -9.42% | 0.93% |
| Issuance of Common Stock | 664.12% | 4,276.54% | -98.41% | -99.93% | 376.13% |
| Repurchase of Common Stock | -- | -- | 100.00% | -234.20% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 95.76% | 98.88% | -820.22% |
| Cash from Financing | -42,119.35% | 83.04% | 98.36% | -104.12% | 266.86% |
| Foreign Exchange rate Adjustments | -6,087.27% | -179.54% | 279.56% | -311.14% | -74.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13,816.47% | 261.06% | 99.55% | -204.67% | 2,779.79% |